Skip to main navigation
  • Home
  • Synthetic Biology
    • The History of Synthetic Biology
  • Living Medicines
    • Designing Synthetic Biotics
  • Pipeline + Programs
    • Partner with Us
  • Clinical Trials
  • Our People
    • Leadership
    • Board of Directors
    • Founders and Advisors
    • Join Us
  • Investors + Media
    • Company Overview
    • News
      • News Releases
      • In the News
    • Events & Presentations
      • Events
      • Presentations
    • Publications
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Corporate Governance
      • Governance Highlights
      • Management Team
      • Board of Directors
      • Committee Composition
      • Board Diversity Matrix
    • Financials
      • Quarterly Results
    • Investor Resources
      • FAQs
      • Contact IR
      • Email Alerts
      • RSS Feeds
explore the
possibilities

Synlogic Therapeutics

Investor Relations

IR menu

  • Overview
  • News
    News Releases In the News
  • Events & Presentations
    Events Presentations
  • Publications
  • Stock Information
    Stock Quote & Chart Analyst Coverage
  • Corporate Governance
    Governance Highlights Leadership Board of Directors Committee Composition Board Diversity Matrix
  • Financials
    SEC Filings Quarterly Results
  • Investor Resources
    FAQs Contact IR Email Alerts RSS Feeds

SEC Filing Details

  • Home
  • Synthetic Biology
    • The History of Synthetic Biology
  • Living Medicines
    • Designing Synthetic Biotics
  • Pipeline + Programs
    • Partner with Us
  • Clinical Trials
  • Our People
    • Leadership
    • Board of Directors
    • Founders and Advisors
    • Join Us
  • Investors + Media
    • Company Overview
    • News
      • News Releases
      • In the News
    • Events & Presentations
      • Events
      • Presentations
    • Publications
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Corporate Governance
      • Governance Highlights
      • Management Team
      • Board of Directors
      • Committee Composition
      • Board Diversity Matrix
    • Financials
      • Quarterly Results
    • Investor Resources
      • FAQs
      • Contact IR
      • Email Alerts
      • RSS Feeds

SEC Filing Details

Document Details

Form
10-Q
Filing Date
May 15, 2018
Document Date
Mar 31, 2018
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Synlogic
Issuer
SYNLOGIC, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.INS - XBRL INSTANCE DOCUMENT
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

Investor Resources

  • Contact IR
  • Investor FAQs
  • RSS Feeds

Investor Email Alerts

Synlogic Therapeutics

Contact

Synlogic

301 Binney St #402
Cambridge, MA 02142

info@synlogictx.com
(617) 401-9975

  • Twitter
  • LinkedIn
  • Youtube
  • Facebook
  • Instagram

Privacy and Terms

© 2023 Synlogic
Privacy Policy